CDCA7 anticorps (AA 201-300)

N° du produit ABIN6988998

Cet anticorps anti-CDCA7 est un anticorps Lapin Polyclonal détectant CDCA7 dans IHC (p). Adapté pour Humain, Rat et Souris.

Aperçu rapide pour CDCA7 anticorps (AA 201-300) (ABIN6988998)

Antigène: CDCA7 (Cell Division Cycle Associated 7 (CDCA7))

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CDCA7 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-CDCA7 anticorps

Épitope: AA 201-300

Réactivité croisée: Humain, Souris, Rat

Homologie: Cow,Sheep,Pig,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human CDCA7

Isotype: IgG

Information d'application

Indications d'application: IHC-P 1:200-400

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur CDCA7

Antigène: CDCA7 (Cell Division Cycle Associated 7 (CDCA7))

Autre désignation: CDCA7

Sujet:

Synonyms: CDCA7, CDCA 7, CDCA-7, Cell division cycle associated 7, JPO1, CDCA7_HUMAN.

Background: Participates in MYC-mediated cell transformation, induces anchorage-independent growth and clonogenicity in lymphoblastoid cells. Insufficient to induce tumorigenicity when overexpressed but contributes to MYC-mediated tumorigenesis. May play a role as transcriptional regulator.

ID gène: 83879

UniProt: Q9BWT1